Premature babies are at risk of death from immature lung development. For this reason, pregnant mothers at risk for preterm delivery are administered dexamethasone (DEX), a synthetic glucocorticoid that promotes fetal lung development. However, exposure to DEX in utero is associated with low birth weight and cardiovascular development pathologies. Moreover, our lab found that DEX administration in-utero leads to a sex-specific increase in stress-induced tachycardia in female, but not male offspring. This project seeks to expand on this preliminary finding of the heart by examining local effectors of activity from the sympathetic system (tyrosine hydroxylase and catechol-o-methyltransferase). Tyrosine hydroxylase was measured as it catalyzes the rate limiting step of norepinephrine synthesis while catechol-O- methyltransferase was studied as it catalyzes the degradation of norepinephrine. Acetylcholinesterase was used to measure parasympathetic activity as it catalyzes the degradation of the primary neurotransmitter of the parasympathetic nervous system, acetylcholine. Analyses of sympathetic as well as parasympathetic activity were done to determine influences of in-utero DEX exposure on autonomic regulation in adulthood. Pregnant rats were administered DEX (0.4 mg/kg, i.p.) or vehicle (20% w/v 2-hydroxypropyl ß- cyclodextran) at gestation days 18-21, with euthanasia of offspring occurring at around the time the offspring reached 13-15 weeks of age. Left ventricles and right atria were pulverized, processed and subjected to western blot analysis to determine expression of proteins of interest. Males exposed to DEX in-utero saw a decrease in tyrosine hydroxylase expression in left ventricle and right atrium when compared to vehicle control, a difference not seen with females. In addition, catechol-o-methyltransferase expression was increased in right atria from male, but not female rats. Acetylcholinesterase expression was reduced in the right atria of female, but not male rats. The present findings suggest reduced norepinephrine signaling in the heart of male, but not female DEX-exposed offspring. Given that we have previously found that female, but not male rats exhibit exaggerated stress-induced tachycardia, our current findings suggest that males possess a sex-specific compensatory mechanism allowing the heart to resist increased sympathetic signaling from the brain, one that females do not possess. The underlying mechanics of this proposed mechanism are unclear, and further investigation is needed in this subject to determine the significance of the findings from our study.
found in the human and rat brain. In Rats, OCT3 is the only known monoamine transporter inhibited by physiological concentrations of corticosteroids. We hypothesized that CORT- mediated inhibition of OCT3 blocks the clearance of serotonin (5-HT) leading to an increase 5-HT receptor-mediated signaling. In experiment 1, due to conflicting reports on the location of OCT3 mRNA in the rat brain, in situ hybridization was performed on brain tissue sections. RNA was extracted from rat brain tissue, reverse transcribed into cDNA, and then polymerase chain reaction (PCR) was performed to generate riboprobe templates. The riboprobe templates were then used for in vitro transcription of digoxigenin (DIG)-labeled riboprobes complementary to OCT3. In experiment 2, 12 rats from an identical cohort were exposed to a chronic restraint stress paradigm (two hours/day for seven days, STRESS group), while the other 12 remained in their home cages (CTRL group). Twenty-four hours after the last stressor, all animals were euthanized and their brains immediately removed and frozen. Bilateral tissue punches were collected from 300μm coronal sections from the CA1 region of the dorsal hippocampus, basolateral amygdala (BLA), and dorsomedial hypothalamus (DMH). The relative OCT2, OCT3, and 5HT2a mRNA levels from each tissue punch were determined via quantitative real-time polymerase chain reaction (qPCR). The results of experiment 1 confirmed the presence of OCT3 mRNA in the CA1, amygdala, and the DMH. The results of experiment 2 show that chronic restraint stress did not alter gene expression for 5-HT2A, OCT2, and OCT3. These data may help reveal new information involving OCT3’s role in the hippocampus, amygdala and DMH in regards to localization and mRNA expression levels after exposure to a stressor.
This hypothesis is supported by previous studies demonstrating that stress-induced elevation of glucocorticoids increases the transcription of C4. I propose that activated glucocorticoid receptors directly increase C4 protein expression as a transcription factor activator. Additionally, I propose that activated glucocorticoid receptors inhibit the expression of the transcription factor nuclear factor-light-chain-enhancer of activated B cells (NF-κB), thereby leading to decreased expression of the C4 inhibitor CUB and Sushi multiple domains 1 (CSMD1).
Glucocorticoid receptors and C4 are richly expressed in the hippocampus, a region critical in memory consolidation, spatial, and declarative memory. I propose that stress-induced upregulation of C4 activity in the hippocampus promotes excessive synaptic pruning, contributing to specific deficits and hippocampal shrinkage seen in schizophrenia. Stress exposure during fetal development and adolescence likely acts through the proposed mechanisms to increase hippocampal C4 activity and subsequent schizophrenia risk. These mechanisms may reveal novel interactions between environmental and genetic risk factors in the etiology of schizophrenia through complement activation.